INNOVAX-ILT-SB
Innovax-ILT-SB is an innovative vaccine that protects against both infectious laryngotracheitis (ILT) and very virulent Marek’s disease (MD). It is a highly effective method of ILT control and provides safe, long-term protection.
Advantages
One single vaccine for long-lasting protection
No respiratory reactions — improved bird performance
Easy to apply — day-old or in ovo hatchery application
No risk of “rolling reactions” and reversion to virulence
How It Works
When Innovax-ILT-SB is applied, it causes an immune response in the vaccinated chicken. The production of antibodies against the I and D glycoproteins stops the actual ILT virus from attaching itself to the cells to prevent infection. Innovax-ILT-SB also results in an immune response against very virulent Marek’s Disease (MD) because it includes the SB-1 strain of chicken herpes virus (serotype 2). It causes the activation of natural killer cells and macrophages, as well as the production of antibodies. Learn more by watching our Mode of Action Video.
Long-Lasting, Reaction-Free Protection
Innovax-ILT-SB uses the herpesvirus of turkey (HVT) as its foundation to deliver long-lasting protection against both ILT and very virulent Marek’s Disease without the costly reactions of conventional live vaccines. Convenient to use, Innovax-ILT-SB can be administered by in ovo injection of 18-day-old chicken embryos and can be easily combined with other respiratory vaccine programs. It supplies long-term immunity and there are no post-vaccine reactions.
Healthier Flocks, Increased Productivity
The innovative Innovax-ILT-SB vaccine has many advantages over traditional live virus vaccines to improve overall flock health and performance. By eliminating the risk of ‘rolling reactions’ flock health is enhanced, and without the need for revaccinations in the field labor costs are also lower. Using an HVT-based vaccine delivers more effective disease control too – live ILT virus cannot be spread in the poultry house and the risk of interference between live vaccines against other respiratory diseases is removed.
Easy-to-Administer
Effective protection begins at the hatchery with in ovo application. As a replacement for Marek’s only vaccination, Innovax-ILT-SB does not change any hatchery vaccination processes.
Convenient to use, Innovax-ILT-SB can be administered in a single dose in the hatchery by the in ovo route and can be easily combined with other respiratory vaccine programs.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global